Child Abuse - Aids Experiment

[eots]

Frustrated by the shroud of secrecy which protects institutions that violate ethical standards in medical research, community action groups are holding an emergency protest on Saturday, March 26 in New York City in front of Incarnation House, the site at which high risk, painful, medical experiments were conducted on children of color--including babies--who were diagnosed HIV positive.

The children were living in foster care at Incarnation House under the guardianship of the City's Administration of Children Services.

Most of the experiments were sponsored by the National Institutes of Health in partnership with various pharmaceutical companies. These experiments were phase I and phase II clinical trials--which involve the highest level of risk and greatest uncertainty about their safety or efficacy.

Additional Information
Guinea Pig Kids

The News Hole

AIDS Alternatives

BBC: Guinea Pig Kids

ACS Admits Guilt

The Nurse's Story

The House That AIDS Built

ICC Investigation

Orphans on Trial

AIDS Tots 'Guinea Pigs'

Shocking Experiments

Campaign for HIV Tests

The experiments were conducted on children who were wards of the state with no parents to protect them or to advocate for their best interest. These children were used as test subjects--guinea pigs--in multiple experiments testing combinations of drugs and vaccines--as many as 7 at a time. The experiments were conducted on these children in violation of the Code of Federal Regulations which prohibits the use of children who are wards of the state from being used in experiments that involve greater than minimal risk.



Child Abuse - Aids Experiment - Kidjacked

 

[waltky]

Hope for an AIDS vaccine...

Antibodies Offer Hope in Battling AIDS
November 29, 2016 - As World AIDS Day approaches Dec. 1, new research is offering hope for further treatment options and, perhaps, even a vaccine.

When the first World AIDS Day was held in 1988, infection was a death sentence. Today, there is lifesaving treatment. In Thailand, researchers eliminated mother-to-child HIV transmission, the first country in Asia to do so. In South Africa, a major clinical trial of an experimental AIDS vaccine aims to reduce the risk of HIV infection by 50 percent. In the United States, researchers are working to use the body's own immune system to keep the virus in check.

One study conducted by the University of Pennsylvania shows promise. "We infuse antibodies into the patients, the participants in the study, and we want to see if those antibodies will control the HIV virus … keep it quiet, and prevent the virus from coming back when we stop anti-retroviral therapy," said Dr. Pablo Tebas, an infectious disease specialist.

Volunteers take part in an event to mark World AIDS Day in Chongqing, China​

Tebas said the research in controlling HIV with antibodies is similar to immunotherapy being done in the field of cancer. HIV, he explains, hides in cells. If a patient stops taking anti-AIDS drugs, the virus comes back. The new technique aims to work as cancer therapy works, where antibodies are used to attack cancer cells. "When you think about oncology and cancer therapy with these immune-based therapies, what people are doing now in that field is to try to boost the immune system to eliminate the cancer cells,” he said. “The problem of eliminating the HIV hideout is similar. You want to eliminate the cells that harbor the virus and, by making the immune system more active, in finding and eliminating those cells."

Researchers have found that the antibodies suppressed the HIV virus for 21 days. The goal is to find a combination of antibodies that can suppress the virus for six months to a year. A new trial using two antibodies is to start in the next couple of months.

Antibodies Offer Hope in Battling AIDS